Ultrasonography of the endometrium and endometrial pathology under tamoxifen treatment

European Journal of Gynaecological Oncology

Volumn 19, Issue 6, 1998, Pages 536-540

  Friedrich, M ^a,b   Villena Hcinsen, C ^a   Mink, D ^a   Endres, V ^a   Reitnauer, K ^b   Schmidt, W ^a  

^a Department of Obstetrics and Gynecology ^*  (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Endometrial thickness; Maturation index; Tamoxifen

Indexed keywords

ESTROGEN RECEPTOR; TAMOXIFEN;

ARTICLE; BREAST CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM ATROPHY; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; ESTROGEN ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NORMAL HUMAN; POLYP; POSTMENOPAUSE; TRANSVAGINAL ECHOGRAPHY; VAGINA EPITHELIUM;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; ENDOMETRIUM; ENDOSONOGRAPHY; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; REFERENCE VALUES; TAMOXIFEN; VAGINA;

EID: 0032429726     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Cole M. P., Jones C. T. A., Todd I. D. H.: "A new antiestrogenic aaent in late breast cancer: an early clinical appraisal of ICI 46,474". Br. J. Cancer, 1975, 11, 571.
2. Fischer B., Costantino J., Redmond C. K., Fisher E. R., Wickerham L., Cronin W. M.: "Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP), B-14". [Prior annotation incorrect] [see comment citations in Medline]. J. Natl. Cancer Inst., 1994, 86, 527.
3. Furr B. A., Jordan V. C.: "The pharmacology and clinical uses of tamoxifen". Pharmacol. Ther, 1984, 25, 127.
4. Coezy E., Borgna J. L., Rochefort H.: "Tamoxifen and metabolites in MCF-7-cells. Correlation between binding to estrogen receptor and inhibition of cell growth". Cancer Res., 1982, 42, 317.
5. Imai Y., Leung C. K. H., Friesen H. G. et al.: "Epidermal growth factor receptors and effect of epidermal growth factor on growth of human breast cancer cells in long term tissue culture". Cancer Res., 1982, 42, 4394.
6. Brunner N., Yee D., Kern F. G. et al.: "Effect of endocrine therapy on growth of T61 human breast cancer xenografts is directly correlated to a specific down-regulation of insulin-like growth factor II (IGF-II)". Eur. J. Cancer, 1993, 29, 562.
7. Taylor I. W., Hodson P. J., Green M. D. et al.: "Effects of tamoxifen on cell cycle progression of synchronous MCF-7 human mammary carcinoma cells". Cancer Res., 1983, 43, 4007.
8. Gottardis M. M., Robinson S. P., Satyaswaroop P. G., Jordan V. C.: "Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse". Cancer Res., 1988, 48, 812.
9. Ismail S. M.: "Pathology of endometrium treated with tamoxifen". J. Clin. Pathol, 1994, 47, 827.
10. Ford M. R. W., Turner M. J., Wood C., Sautter W.: "Endometriosis developing during tamoxifen therapy". Am. J. Obstet. Gynecol., 1988, 158, 119.
11. Corley D., Rowe J., Curtis M. T., Hogan W. M., Noumoff J. S., LiVilsi V. A.: "Postmenopausal bleeding from unusual polyps in woman on chronic tamoxifen therapy". Obstet. Gynecol., 1992, 79, 111.
12. Fornander T., Rutquist L. E., Cedermark B., Glas U., Mattson A.: "Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers". Lancet, 1989, 1, 117.
13. Hardell L.: "Tamoxifen as a risk factor for carcinoma of corpus uteri". Lancet, 1988, 3, 563.
14. Killacke M. A., Hakes T. B., Pierce V. K.: "Endometrial adenocarcinoma in breast cancer patients receiving antiestrogens". Cancer Treat. Rep., 1985, 69, 237.
15. Soost H. J., Baur S.: "Gynäkologische Zytodiagnostik. [Gynecologic cytologic diagnostics]". 5th Edition. Stuttgart, Thieme, 1990.
16. Koss L. G.: "Diagnostic Cytology and its Histopathologic bases". 3rd ed. Philadelphia, Lippincott, 1979.
17. Berg J. W., Dunfee G. R.: "Cytological presentation of endometrial carcinoma". Cancer, 1958, 11, 158.
18. Wied G. L., Bibbo M., Keebler C.: "Evaluation of endocrinologic condition by exfoliative cytology". In: Wied G. L., Keebler C. M., Koss L. C., Reagan J. W., eds. "Compendium of diagnostic cytology". 6th ed. Chicago, Tutorial of Cytology, 1988, 33.
19. Koss L. G.: "Cytologic evaluation of the endocrine status of the woman". In: Koss L. G., ed. "Diagnostic Cytology and its Histopathologic bases". 3rd ed. Philadelphia, Lippincott, 1979, 203.
20. Boccardo F., Bruzzi P., Rubagotti A., Nicolo G., Rosso R.: "Estrogen-like action of tamoxifen on vaginal epithelium in breast cancer patients". Oncology, 1981, 30, 281.
21. Ferrazzi E., Cartei G., Mattarazzo R., Fiorentino M.: "Estrogen-like of tamoxifen on vaginal epithelium". Br. Med. J., 1977, 1, 1351.
22. Lahti E., Vuopala S., Kauppila A., Blanco G., Ruokonen A., Laatikainen T.: "Maturation of vaginal and endometrial epithelium in poslmenopausal breast cancer patients receiving long-term tamoxifen". Gynecol. Oncol., 1994, 55, 410.
23. Carter J., Carson L. F., Byers L. et al.: "Transvaginal ultrasound in gynecologic oncology". Obstet. Gynecol. Surv., 1991, 46, 687.
24. Lahti E., Blanco G., Kauppila A., Apaja-Sarkkinen M., Taskinen P., Laatikainen T.: "Endometrial changes in post-menopausal breast cancer patients receiving tamoxifen". Obstet. Gynecol., 1993, 81, 660.
25. Osmers R., Volksen M., Schauer A.: "Vaginosonography for early detection of endometrial carcinoma". Lancet, 1990, 335, 1569.
26. Cohen I., Rosen D. J. D., Tepper R., Cordoba M., Alteras M. M., Byeth Y.: "Ultrasonographic evaluation of the endometrium with correlation to endometrial sampling in post-menopausal patients treated with tamoxifen". J. Ultrasound Med., 1993, 5, 275.
27. Nasri M., Coast G.: "Correlation of ultrasound findings and endometrial histopathology in postmenopausal women". Br. J. Obstet. Gynecol., 1989, 96, 1333.
28. Kedar P. R., Bourne T. H., Powles T. J., Collins W. P., Ashley S. E., Cosgrove D. O., Campbell S.: "Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomixed breast cancer prevention trial". Lancet, 1994, 343, 1318.
29. Cecchini S., Ciatto S., Bonardi R. et at.: "Screening by ultrasonography for endometrial carcinoma in postmenopausal breast cancer patients under adjuvant tamoxifen". Gynecol. Oncol, 1996, 60, 409.
30. Granberg S., Wikland M., Karlsson B., Norstrom A., Friberg L. G.: "Endometrial thickness as measured by endovaginal ultrasonography for identifying endometrial abnormality". Am. J. Obstet. Gynecol., 1991, 164, 47.
31. Cohen I., Tepper R., Rosen D. J. D. et al.: "Endometrial changes with tamoxifen: comparison between tamoxifen treated and nontreated asymptomatic postmenopausal breast cancer patients". Gynecol. Oncol., 1994, 52, 185.
32. Goldstein S. R., Nachtigall M., Snyder J. R., Nachtigall L.: "Endometrial assessment by vaginal ultrasonography before endometrial sampling in patients with postmenopausal bleeding". Am. J. Obstet. Gynecol., 1990, 63, 119.
33. Varner R. E., Sparks J. M., Cameron C. D., Roberts L. L., Soong S. J.: "Transvaginal sonography of the endometrium in postmenopausal women". Obstet. Gynecol, 1991, 78, 195.
34. Hulka C. A., Hall D. A.: "Endometrial abnormalities associated with tamoxifen therapy for breast cancer. Sonographic and pathologic correlations". Am. J. Roentgenol., 1993, 160, 809.
35. Goldstein S. R.: "Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen". Am. J. Obstet. Gynecol., 1994, 170, 447.
36. Bornstein J., Auslender R., Pascal B., Guttermann E., Isakov D., Abramovici H.: "Diagnostic pitfalls of ultrasonographic uterine screening in women treated with tamoxifen". J. Reprod. Med., 1994, 39, 674.
37. Robinson D. C., Bloss J. D., Schiano M. A.: "A retrospective study of tamoxifen and endometrial cancer in breast cancer patients". Gynecol. Oncol, 1995, 59, 186.
38. Stewart H. J.: "The Scottish trial of adjuvant tamoxifen in node-negative breast cancer. Scottish Cancer Trials Breast Group". Monogr. Natl. Cancer Inst., 1992, 11, 117.
39. Cohen I., Tepper R., Rosen D. J. D.: "Continuous tamoxifen treatment in asymptomatic postmenopausal breast cancer patients does not cause aggravation of endometrial pathologies". Gynecol. Oncol, 1994, 55, 138.
40. Touraine P., Driguez P., Cartier I., Yaneva H., Kuttenn F., Mauvais-Jarvis P.: "Lack of induction of endometrial hyperplasia with tamoxifen". Lancet, 1995, 345, 254.